Sustained release hydrogel for durable locoregional chemoimmunotherapy for BRAF-mutated melanoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sustained release hydrogel for durable locoregional chemoimmunotherapy for BRAF-mutated melanoma

Published:2023-05 Issue: Volume:357 Page:655-668
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Kim Jihoon,Archer Paul A.,Manspeaker Margaret P.,Avecilla Alexa R.C.,Pollack Brian P.,Thomas Susan N.

Funder

National Science Foundation

National Institutes of Health

U.S. Department of Defense

Department of Defense Peer Reviewed Cancer Research Program

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference44 articles.

1. Vemurafenib: the first drug approved for BRAF-mutant cancer;Bollag;Nat. Rev. Drug Discov.,2012

2. BRAF in melanoma: current strategies and future directions;Salama;Clin. Cancer Res.,2013

3. Targeting BRAF in advanced melanoma: a first step toward manageable disease;Vultur;Clin. Cancer Res.,2011

4. Similar but different: distinct roles for KRAS and BRAF oncogenes in colorectal cancer development and therapy resistance;Morkel;Oncotarget,2015

5. Mutant BRAF melanomas—dependence and resistance;Poulikakos;Cancer Cell,2011

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multifunctional hydrogels based on photothermal therapy: A prospective platform for the postoperative management of melanoma;Journal of Controlled Release;2024-07

2. Corrigendum to “Sustained release hydrogel for durable locoregional chemoimmunotherapy for BRAF-mutated melanoma” [Journal of Controlled Release 357 (2023) 655–668];Journal of Controlled Release;2024-02

3. Biomineralized Polydopamine Nanoparticle-Based Sodium Alginate Hydrogels for Delivery of Anti-serine/Threonine Protein Kinase B-Rapidly Accelerated Fibrosarcoma siRNA for Metastatic Melanoma Therapy;ACS Nano;2023-09-10

4. Injectable Poloxamer Hydrogels for Local Cancer Therapy;Gels;2023-07-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3